HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Antibody directed therapy for leukemia].

Abstract
Recently, monoclonal antibody(MoAb) therapies which direct at antigens such as CD33, CD45 and GM-CSF receptors on myeloid leukemia cells have been in progress. There are three major MoAb therapies against acute myeloid leukemia(AML), which include unconjugated MoAb, MoAb conjugated with chemotherapy or toxins, and MoAb conjugated with radioisotopes. Gemtuzumab ozogamicin is consisting of an engineered human anti-CD33 antibody linked with the potent anti-tumor antibiotic calicheamicin, which is the most effective for AML. However, recent studies suggested that calicheamicin was also pumped out by multi-drug resistance(MDR) related P-glycoprotein. The combination therapy with MDR modifiers may improve the effect of gemtuzumab ozogamicin.
AuthorsAkihiro Takeshita, Kensuke Naito, Ryuzo Ohno
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 60 Issue 3 Pg. 517-24 (Mar 2002) ISSN: 0047-1852 [Print] Japan
PMID11904967 (Publication Type: Journal Article)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Aminoglycosides
  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • Cd33 protein, mouse
  • Iodine Radioisotopes
  • Sialic Acid Binding Ig-like Lectin 3
  • Gemtuzumab
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Aminoglycosides
  • Animals
  • Anti-Bacterial Agents (pharmacology, therapeutic use)
  • Antibodies, Monoclonal (pharmacology, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antigens, CD (immunology)
  • Antigens, Differentiation, Myelomonocytic (immunology)
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Gemtuzumab
  • Humans
  • Iodine Radioisotopes (therapeutic use)
  • Leukemia, Myeloid, Acute (pathology, therapy)
  • Mice
  • Sialic Acid Binding Ig-like Lectin 3
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: